Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307042018> ?p ?o ?g. }
- W4307042018 endingPage "649" @default.
- W4307042018 startingPage "638" @default.
- W4307042018 abstract "Abstract This article describes studies on the design, synthesis, and biological evaluation of pyrazole‐containing β‐amino carbonyl compounds ( 5a – 5q ) as DPP‐4 inhibitors and anti‐diabetic agents. In contrast, mannich reactions went smoothly with bismuth nitrate (Bi (NO 3 ) 3 ) catalyst in the presence of ethanol and produced pyrazole‐containing β‐amino carbonyl compounds in good yield. Molecular docking studies of designed derivatives with DPP‐4 enzyme (PDB: 2OLE), compounds 5d , 5h , 5j , and 5k showed excellent interaction. 3D QSAR and pharmacophoric model studies were also carried out. ADMET parameters, pharmacokinetic properties, and in vivo toxicity studies further confirmed that all the designed compounds were found to have good bioavailability and were less toxic. Further, these compounds were evaluated as enzyme‐based in vitro DPP‐4 inhibitory activity, and 5d , 5h , 5i , 5j , and 5k exhibited IC 50 toward DPP‐4 enzyme of 10.52, 10.41, 5.55, 4.16, and 7.5 nM, respectively. The most potent compound, 5j , was further selected for in vivo anti‐diabetic activity using an STZ‐induced diabetic mice model, and 5j showed a significant diabetic control effect." @default.
- W4307042018 created "2022-10-23" @default.
- W4307042018 creator A5009441164 @default.
- W4307042018 creator A5014832721 @default.
- W4307042018 creator A5019813792 @default.
- W4307042018 creator A5039692617 @default.
- W4307042018 creator A5047629453 @default.
- W4307042018 creator A5048813998 @default.
- W4307042018 creator A5074735723 @default.
- W4307042018 creator A5086370031 @default.
- W4307042018 creator A5086801859 @default.
- W4307042018 creator A5091735282 @default.
- W4307042018 date "2022-11-14" @default.
- W4307042018 modified "2023-10-17" @default.
- W4307042018 title "Lead modification via computational studies: Synthesis of pyrazole‐containing β‐amino carbonyls for the treatment of type 2 diabetes" @default.
- W4307042018 cites W1965671858 @default.
- W4307042018 cites W2004454394 @default.
- W4307042018 cites W2004592535 @default.
- W4307042018 cites W2011094352 @default.
- W4307042018 cites W2023232134 @default.
- W4307042018 cites W2024311391 @default.
- W4307042018 cites W2025299147 @default.
- W4307042018 cites W2030250242 @default.
- W4307042018 cites W2031386586 @default.
- W4307042018 cites W2068026234 @default.
- W4307042018 cites W2076724959 @default.
- W4307042018 cites W2080087201 @default.
- W4307042018 cites W2085849265 @default.
- W4307042018 cites W2088828287 @default.
- W4307042018 cites W2140415161 @default.
- W4307042018 cites W2149461013 @default.
- W4307042018 cites W2346652445 @default.
- W4307042018 cites W2552229243 @default.
- W4307042018 cites W2576791132 @default.
- W4307042018 cites W2591780019 @default.
- W4307042018 cites W2592839264 @default.
- W4307042018 cites W2593436234 @default.
- W4307042018 cites W2766061760 @default.
- W4307042018 cites W2799603177 @default.
- W4307042018 cites W2801088198 @default.
- W4307042018 cites W2911657223 @default.
- W4307042018 cites W2946454911 @default.
- W4307042018 cites W2947176388 @default.
- W4307042018 cites W2962983903 @default.
- W4307042018 cites W2972830734 @default.
- W4307042018 cites W2996190144 @default.
- W4307042018 cites W2998298946 @default.
- W4307042018 cites W3038493388 @default.
- W4307042018 cites W3048065091 @default.
- W4307042018 cites W3088562908 @default.
- W4307042018 cites W3097506464 @default.
- W4307042018 cites W3173242815 @default.
- W4307042018 cites W4205718468 @default.
- W4307042018 cites W4207001068 @default.
- W4307042018 cites W4288073009 @default.
- W4307042018 doi "https://doi.org/10.1111/cbdd.14157" @default.
- W4307042018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36271321" @default.
- W4307042018 hasPublicationYear "2022" @default.
- W4307042018 type Work @default.
- W4307042018 citedByCount "0" @default.
- W4307042018 crossrefType "journal-article" @default.
- W4307042018 hasAuthorship W4307042018A5009441164 @default.
- W4307042018 hasAuthorship W4307042018A5014832721 @default.
- W4307042018 hasAuthorship W4307042018A5019813792 @default.
- W4307042018 hasAuthorship W4307042018A5039692617 @default.
- W4307042018 hasAuthorship W4307042018A5047629453 @default.
- W4307042018 hasAuthorship W4307042018A5048813998 @default.
- W4307042018 hasAuthorship W4307042018A5074735723 @default.
- W4307042018 hasAuthorship W4307042018A5086370031 @default.
- W4307042018 hasAuthorship W4307042018A5086801859 @default.
- W4307042018 hasAuthorship W4307042018A5091735282 @default.
- W4307042018 hasConcept C150903083 @default.
- W4307042018 hasConcept C159110408 @default.
- W4307042018 hasConcept C178790620 @default.
- W4307042018 hasConcept C181199279 @default.
- W4307042018 hasConcept C181389837 @default.
- W4307042018 hasConcept C185592680 @default.
- W4307042018 hasConcept C201399114 @default.
- W4307042018 hasConcept C202751555 @default.
- W4307042018 hasConcept C207001950 @default.
- W4307042018 hasConcept C21951064 @default.
- W4307042018 hasConcept C2777682936 @default.
- W4307042018 hasConcept C2777752112 @default.
- W4307042018 hasConcept C41685203 @default.
- W4307042018 hasConcept C515207424 @default.
- W4307042018 hasConcept C55493867 @default.
- W4307042018 hasConcept C71240020 @default.
- W4307042018 hasConcept C71924100 @default.
- W4307042018 hasConcept C86803240 @default.
- W4307042018 hasConcept C98274493 @default.
- W4307042018 hasConceptScore W4307042018C150903083 @default.
- W4307042018 hasConceptScore W4307042018C159110408 @default.
- W4307042018 hasConceptScore W4307042018C178790620 @default.
- W4307042018 hasConceptScore W4307042018C181199279 @default.
- W4307042018 hasConceptScore W4307042018C181389837 @default.
- W4307042018 hasConceptScore W4307042018C185592680 @default.
- W4307042018 hasConceptScore W4307042018C201399114 @default.
- W4307042018 hasConceptScore W4307042018C202751555 @default.